Background: The protective effect of antenatal corticosteroids (ACS) in preterm infants has been well established but it remains unclear in growth-restricted fetuses. Furthermore, a substantial number of pregnant women receive only incomplete ACS treatment because of late presentation or imminent delivery at arrival to the delivery site. How this affects neonatal outcomes in small for gestational age (SGA) infants is not rigorously described. We evaluated the influence of ACS completion on in-hospital neonatal outcomes in very low birthweight (VLBW) infants, depending on appropriately or inappropriately grown singletons.
Methods: Electronic data were retrieved from the Korean Neonatal Network database between 2013 and 2017. We assessed perinatal and neonatal characteristics and neonatal mortality and morbidities. Multivariable logistic regression analyses were performed to evaluate neonatal outcome variables influenced by an incomplete as compared to a complete course of ACS in non-SGA and SGA infants.
Results: In total, 4441 VLBW infants were included in the study. Complete ACS treatment significantly reduced the risk for death before 28 days of life [odds ratio (OR) = 0.525, 95% confidence interval (CI) = 0.414-0.666], death before neonatal intensive care unit discharge (OR = 0.606, 95% CI = 0.489-0.750), respiratory distress syndrome (OR = 0.634, 95% CI = 0.507-0.793), severe intraventricular hemorrhage (OR = 0.539, 95% CI = 0.424-0.684)], and necrotizing enterocolitis (OR = 0.720, 95% CI = 0.561-0.924) in non-SGA infants. ACS completion did not change the risk for neonatal outcomes in SGA infants.
Conclusions: This study suggests that a complete course of ACS has a favorable effect on several neonatal outcomes in non-SGA VLBW infants. There were no significant differences between the complete exposure and incomplete exposure group in SGA infants.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pedneo.2021.08.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pregnancy, delivery, and neonatal outcomes among women with beta-thalassemia major: a population-based study of a large US database.
Arch Gynecol Obstet
January 2025
Department of Obstetrics & Gynecology, University of Tabuk, Tabuk, Saudi Arabia.
Purpose: We explored the effect of beta-thalassemia major on pregnancy and delivery outcomes in non-endemic area, utilizing USA population database.
Methods: This is a retrospective study utilizing data from the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample. A cohort of all deliveries between 2011 and 2014 was created using ICD-9 codes.
[Clinical practice guidelines for the diagnosis and treatment of anemia of prematurity (2025)].
Zhongguo Dang Dai Er Ke Za Zhi
January 2025
Anemia of prematurity (AOP) is a multifactorial condition associated with congenital iron deficiency, low erythropoietin levels, a short lifespan of red blood cells, and iatrogenic blood loss. AOP is a common complication in premature infants that can adversely affect growth, development, and long-term neurocognitive outcomes. To standardize the diagnosis and treatment of AOP, the Neonatal Clinical Practice Guidelines Expert Committee and the Neonatal Evidence-Based Medicine Group of the Commission of Neonatal Medicine of the Cross-Strait Medical and Health Exchange Association, along with the Editorial Office of the , have developed the "Clinical practice guidelines for the diagnosis and treatment of anemia of prematurity (2025)", based on the World Health Organization's handbook for guideline development and the formulation/revision principles of Chinese clinical practice guidelines.
View Article and Find Full Text PDFA Rare Encounter: Diagnosing and Managing Congenital Malaria in a Neonate.
J Coll Physicians Surg Pak
January 2025
Department of Paediatrics, National University of Medical Sciences / PEMH, Rawalpindi, Pakistan.
Null.
View Article and Find Full Text PDFThe Role of Preoperative Inflammatory Markers in Cervical Cerclage Success.
J Coll Physicians Surg Pak
January 2025
Department of Obstetrics and Gynaecology, Health Sciences University, Bursa Yuksek Ihtisas Training and Research Hospital,
Bursa, Turkiye.
Objective: To compare the inflammatory markers between therapeutic and emergency cerclage and assess the predictive role of inflammatory markers for the latency period.
Study Design: Descriptive study. Place and Duration of the Study: Department of Obstetrics and Gynaecology, Bursa Yuksek Ihtisas Training and Research Hospital, Turkiye, from January 2016 to September 2022.
Assessing psychosocial risk factors in children with Sickle Cell Disease.
BMC Health Serv Res
January 2025
Indiana University School of Medicine, 410 W 10th St, Suite 2000A, Indianapolis, IN, 46202, USA.
Background: Individuals with Sickle Cell Disease (SCD) are a minoritized and marginalized community that have disparate health outcomes as a result of systemic racism and disease-related stigma. The purpose of this study was to determine the psychosocial risk factors for families caring for children with SCD at a pediatric SCD center through use of the Psychosocial Assessment Tool (PAT), a validated caregiver-report screener.
Methods: The PAT was administered annually during routine clinical visits and scored by the SCD Social Worker to provide tailored resources to families.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!